References
- 1. Chi CC, Kirtschig G, Baldo M, Lewis F, Wang SH, Wojnarowska F. Systemic review and meta-analysis of randomized controlled trials on topical interventions for genital lichen sclerosus. J Am Acad Dermatol 2012;67:305-12.10.1016/j.jaad.2012.02.044
- 2. Smith SD, Fischer G. Paediatric vulvar lichen sclerosus. Australas J Dermatol 2009;50:243-8.10.1111/j.1440-0960.2009.00530.x
- 3. Bradford J, Fischer G. Long-term management of vulval lichen sclerosus in adult women. Aust N Z J Obstet Gynaecol 2010;50:148-52.10.1111/j.1479-828X.2010.01142.x
- 4. Edmonds EV, Hunt S, Hawkins D, Dinneen M, Francis N, Bunker CB. Clinical parameters in male genital lichen sclerosus: a case series of 329 patients. J Eur Acad Dermatol Venereol 2012;26:730-7.10.1111/j.1468-3083.2011.04155.x
- 5. Meyrick Tomas RH, Ridley CM, McGibbon DH, Black MM. Lichen sclerosus et atrophicus and autoimmunity - a study of 350 women. Br J Dermatol 1988;118:41-6.10.1111/j.1365-2133.1988.tb01748.x
- 6. Harrington CI, Dunsmore IR. An investigation into the incidence of auto-immune disorders in patients with lichen sclerosus et atrophicus. Br J Dermatol 1981;104:563-6.10.1111/j.1365-2133.1981.tb08172.x
- 7. Oyama N, Chan I, Neill SM, Hamada T, South AP, Wessagowit V, et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet 2003;362:118-23.10.1016/S0140-6736(03)13863-9
- 8. Bracco GL, Carli P, Sonni L, Maestrini G, De Marco A, Taddei GL, et al. Clinical and histologic eff ects of topical treatments of vulval lichen sclerosus. A critical evaluation. J Reprod Med 1993;38:37-40.
- 9. Kiss A, Csontai A, Pirot L, Nyirady P, Merksz M, Kiraly L. Th e response of balanitis xerotica obliterans to local steroid application compared with placebo in children. J Urol 2001;165:219-20.10.1097/00005392-200101000-00062
- 10. Patrizi A, Gurioli C, Medri M, Neri I. Childhood lichen sclerosus: a long-term follow up. Pediatr Dermatol 2010;27:101-3.10.1111/j.1525-1470.2009.01050.x
- 11. Sideri M, Origoni M, Spinaci L, Ferrari A. Topical testosterone in the treatment of vulvar lichen sclerosus. Int J Gynaecol Obstet 1994;46:53-6.10.1016/0020-7292(94)90309-3
- 12. Paslin D. Treatment of lichen sclerosus with topical dihydrotestosterone. Obstet Gynecol 1991;78:1046-9.
- 13. Paslin D. Androgens in the topical treatment of lichen sclerosus. Int J Dermatol 1996;35:298-301.10.1111/j.1365-4362.1996.tb03009.x8786194
- 14. Cattaneo A, Carli P, De Marco A, Sonni L, Bracco G, De Magnis A, et al. Testosterone maintenance therapy. Eff ects on vulvar lichen sclerosus treated with clobetasol propionate. J Reprod Med 1996;41:99-102.
- 15. Goldstein AT, Creasey A, Pfau R, Phillips D, Burrows LJ. A double-blind, randomized contolled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. J Am Acad Dermatol 2011;64:99-104.10.1016/j.jaad.2010.06.01121353334
- 16. Oskay T, Sezer HK, Genc C, Kutluay L. Pimecrolimus 1% cream in the treatment of vulvar lichen sclerosus in postmenopausal women. Int J Dermatol 2007;46:527-32.10.1111/j.1365-4632.2006.03185.x17472689
- 17. Kim GW, Park HJ, Kim HS, Kim SH, Ko HC, Kim BS, et al. Topical tacrolimus ointment for the treatment of lichen sclerosus, comparing genital and extragenital involvment. J Dermatol 2012;39:145-50.10.1111/j.1346-8138.2011.01384.x22044240
- 18. Virgili A, Lauriola MM, Mantovani L, Corazza M. Vulvar lichen sclerosus: 11 women treated with tacrolimus 0.1% ointment. Acta Derm Venereol 2007;87:69-72.10.2340/00015555-017117225019
- 19. Margesson LJ, Danby FW. Diseases and disorders of female geniatlia. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leff ell DY, Wolff K. Fitzpatrick΄s Dermatology in general medicine. 8th ed. New York: McGraw Hill Medical; 2012. p. 883-5.
- 20. McPherson T, Cooper S. Vulval lichen sclerosus and lichen planus. Dermatol Th er 2010;23:523-32. 10.1111/j.1529-8019.2010.01355.x20868406